These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 22330761)

  • 1. Protein L: a novel reagent for the detection of chimeric antigen receptor (CAR) expression by flow cytometry.
    Zheng Z; Chinnasamy N; Morgan RA
    J Transl Med; 2012 Feb; 10():29. PubMed ID: 22330761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors.
    De Oliveira SN; Wang J; Ryan C; Morrison SL; Kohn DB; Hollis RP
    J Transl Med; 2013 Jan; 11():23. PubMed ID: 23360526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
    Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
    J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains.
    Alabanza L; Pegues M; Geldres C; Shi V; Wiltzius JJW; Sievers SA; Yang S; Kochenderfer JN
    Mol Ther; 2017 Nov; 25(11):2452-2465. PubMed ID: 28807568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.
    Zaninelli S; Meli C; Borleri G; Quaroni M; Pavoni C; Gaipa G; Biondi A; Introna M; Golay J; Rambaldi A; Rambaldi B
    Cytometry A; 2024 Feb; 105(2):112-123. PubMed ID: 37707318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity.
    Song DG; Ye Q; Poussin M; Liu L; Figini M; Powell DJ
    Oncotarget; 2015 Aug; 6(25):21533-46. PubMed ID: 26101914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel luciferase-based assay for the detection of Chimeric Antigen Receptors.
    Gopalakrishnan R; Matta H; Choi S; Natarajan V; Prins R; Gong S; Zenunovic A; Narasappa N; Patel F; Prakash R; Chaudhary V; Sikri V; Chitnis SD; Kochegarov A; Wang D; Falat M; Kahn M; Keerthipati PS; Sharma N; Lenka J; Stieben TM; Braun J; Batra A; Purvis K; Ito K; Lee JH; Jeronimo A; Zamora HM; Membreno A; Qiu Q; Peshin S; Namburu L; Chaudhary PM
    Sci Rep; 2019 Feb; 9(1):1957. PubMed ID: 30760795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines.
    Schneider D; Xiong Y; Wu D; Nӧlle V; Schmitz S; Haso W; Kaiser A; Dropulic B; Orentas RJ
    J Immunother Cancer; 2017; 5():42. PubMed ID: 28515942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity.
    Zhao Y; Wang QJ; Yang S; Kochenderfer JN; Zheng Z; Zhong X; Sadelain M; Eshhar Z; Rosenberg SA; Morgan RA
    J Immunol; 2009 Nov; 183(9):5563-74. PubMed ID: 19843940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells.
    Beard RE; Zheng Z; Lagisetty KH; Burns WR; Tran E; Hewitt SM; Abate-Daga D; Rosati SF; Fine HA; Ferrone S; Rosenberg SA; Morgan RA
    J Immunother Cancer; 2014; 2():25. PubMed ID: 25197555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel anti-CD19 chimeric antigen receptors with humanized scFv (single-chain variable fragment) trigger leukemia cell killing.
    Qian L; Li D; Ma L; He T; Qi F; Shen J; Lu XA
    Cell Immunol; 2016; 304-305():49-54. PubMed ID: 26996927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy.
    Jamnani FR; Rahbarizadeh F; Shokrgozar MA; Mahboudi F; Ahmadvand D; Sharifzadeh Z; Parhamifar L; Moghimi SM
    Biochim Biophys Acta; 2014 Jan; 1840(1):378-86. PubMed ID: 24076235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR.
    Schanda N; Sauer T; Kunz A; Hückelhoven-Krauss A; Neuber B; Wang L; Hinkelbein M; Sedloev D; He B; Schubert ML; Müller-Tidow C; Schmitt M; Schmitt A
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells.
    Schreiber S; Dressler LS; Loffredo-Verde E; Asen T; Färber S; Wang W; Groll T; Chakraborty A; Kolbe F; Kreer C; Kosinska AD; Simon S; Urban S; Klein F; Riddell SR; Protzer U
    Front Immunol; 2024; 15():1340619. PubMed ID: 38711498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies.
    Ali A; Kitchen SG; Chen ISY; Ng HL; Zack JA; Yang OO
    J Virol; 2016 Aug; 90(15):6999-7006. PubMed ID: 27226366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma.
    Mihara K; Yanagihara K; Takigahira M; Kitanaka A; Imai C; Bhattacharyya J; Kubo T; Takei Y; Yasunaga S; Takihara Y; Kimura A
    Br J Haematol; 2010 Oct; 151(1):37-46. PubMed ID: 20678160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma.
    Zhang C; Wang L; Zhang Q; Shen J; Huang X; Wang M; Huang Y; Chen J; Xu Y; Zhao W; Qi Y; Li Y; Ou Y; Yang Z; Qian C
    Front Immunol; 2023; 14():1182409. PubMed ID: 37304295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel multimeric sCD19-streptavidin fusion protein for functional detection and selective expansion of CD19-targeted CAR-T cells.
    Lian H; Jiang J; Wang Y; Yu X; Zheng R; Long J; Zhou M; Zhou S; Wei C; Zhao A; Gao J
    Cancer Med; 2022 Aug; 11(15):2978-2989. PubMed ID: 35621033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells.
    Reichman A; Kunz A; Joedicke JJ; Höpken UE; Keib A; Neuber B; Sedloev D; Wang L; Jiang G; Hückelhoven-Krauss A; Eberhardt F; Müller-Tidow C; Wermke M; Rehm A; Schmitt M; Schmitt A
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells.
    An N; Tao Z; Li S; Xing H; Tang K; Tian Z; Rao Q; Wang M; Wang J
    Oncotarget; 2016 Mar; 7(9):10638-49. PubMed ID: 26840021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.